What is pegfilgrastim?
Pegfilgrastim is a general drug that is commonly launched on the market under the Neulasta® brand. The doctor may prescribe this to patients with cancer undergoing chemotherapy. Although it is not a drug chemotherapy, it can be used to reduce the risk of infection that chemotherapy can cause. It is a cure for factors stimulating a colony that promotes the growth of new white blood cells produced by bone marrow. Sometimes the doctor may also prescribe pegfilgrastim for patients who undergo stem cell transplantation. Teens will usually be prescribed in advance filled with a syringe that contains 6 milligrams (mg) of the drug. It does not have to be served every day, but the doctor will rather explain when to use it. Pegfilgrastim is not intended for use within one day after a dose of chemotherapy or 14 days before it, as patients will be in the Hosmteteenth risk of side effects.
The syringes must be stored in the refrigerator. Before using the dose, the patient should allow the syringe to sit at a room temperature for 30 minutes. After the sterilization of the areaThe skin is injected subcutaneously or under the skin. It should never be injected into a broken, bruised or irritated skin. Patients should choose a new place of injection for each dose.
Some side effects may occur when using pegfilgrastim, which should be reported to doctors if they are difficult or serious. Patients may notice injection sites developing lumps, bruises or swelling. This area can also be reddish or tender to the touch. Bone pain may also develop, which can be released in the over -the -counter summer pain such as acetaminophen. Patients should avoid aspirin use.
Rarely, more serious side effects may occur that requires me installed HELP. Pegfilgrastim can rarely cause damage to the spleen, which is life -threatening. Symptoms of this complication may include severe stomach or abdomen pain. DAlso serious side effects may include shoulder pain, quick breathing or breathing problems. Patients should remember the symptoms of infection that may include fever, sore throat and chills.
Before accepting pegfilgrastim to help prevent infections, patients must publish their other health conditions, medicines and supplements. Since 2011, it is not known whether this medicine can go to breast milk. Women who are pregnant should prevent its use whenever possible. Pegfilgrastim should not be used during radiation therapy or those who have certain allergies such as latex allergies. This medicine may disrupt the results of some laboratory tests.